Totus | News

We’ve come a long way, fast. Read about our journey.

2022

Totus Medicines CEO to Present at Next-Generation Undruggable Conference

PR Newswire 10 11 2022

Totus Medicines Announces Global Pharma Leader Tom Hughes as Board Chair & Creation of Scientific Advisory Board

PR Newswire 05 05 2022

Totus Medicines Announces New San Francisco Bay Area Headquarters & Expanded Lab Space

PR Newswire 03 31 2022

East Coast biotech company relocates HQ to Emeryville

San Francisco Business Times 03 31 2022

Cambridge biotech relocates to West Coast

Boston Business Journal 03 31 2022

Totus Medicines Partners with Mila to Advance Drug Discovery Technologies in Mission to Treat the Untreatable

PR Newswire 03 24 2022

Totus Medicines Hires Corporate Strategy Leader Laura Miller

PR Newswire 03 23 2022

CNIO and Totus Medicines Form Partnership to Develop New Generation of Anti-Cancer Molecules

03 17 2022

The future of pharma and health care will come in small (molecule) packages

STAT 03 01 2022

Expert Clinical Developer Dr. Ovid Trifan and Veteran Drug Hunter Dr. Wei Chen Bring Decades of Complex Drug Development Experience to Totus Medicines

PR Newswire 02 23 2022

Totus Medicines to Present at 2022 J.P. Morgan HealthCare Conference

PR Newsire 01 11 2022

Totus Medicines Appoints Chief People Officer Daisy Chhokar and Chief Financial Officer Sam Singer to Senior Leadership Team

PR Newswire 01 06 2022

2021

Totus Medicines Emerges from Stealth with Revolutionary Drug Program Targeting PI3K-Alpha Oncogene

PR Newswire 12 09 2021

This Biotech Company Raised $40 Million To Develop Treatments For ‘Undruggable’ Diseases

Forbes 12 09 2021

Rear view of some Totus team members who are viewing a monitor with some data visualization on it. One team member is using the data to make a point.

A breakthrough cancer drug already, and more on the way.